Anti-thymocyte globulin with CsA and MMF as GVHD prophylaxis in nonmyeloablative HLA-mismatched allogeneic HCT

Nonmyeloablative regimens are used for allogeneic hematopoietic cell transplantation (HCT) of older or medically unfit patients, but successful outcome is still hindered by graft-versus-host disease (GVHD), especially in the setting of HLA-mismatched HCT. New GVHD prophylaxis strategies are emerging...

Full description

Saved in:
Bibliographic Details
Published in:Bone Marrow Transplant
Main Authors: van der Velden, Walter J. F. M., Choi, Goda, de Witte, Moniek A., van der Meer, Arnold, de Haan, Anton F. J., Blijlevens, Nicole M. A., Huls, Gerwin, Kuball, Jürgen, van Dorp, Suzanne
Format: Artigo
Language:Inglês
Published: Nature Publishing Group UK 2021
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8214052/
https://ncbi.nlm.nih.gov/pubmed/34148060
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41409-021-01369-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items